NutriBand (NTRB) Free Cash Flow Growth (5y) (2021 - 2026)
NutriBand (NTRB) Free Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -12.09% |
| Jan 31, 2026 | -54.49% |
| Oct 31, 2025 | -81.27% |
| Jul 31, 2025 | -63.58% |
| Apr 30, 2025 | -46.12% |
| Jan 31, 2025 | -60.18% |
| Oct 31, 2024 | -31.73% |
| Jul 31, 2024 | -46.07% |
| Apr 30, 2024 | -25.25% |
| Jan 31, 2024 | -22.09% |
| Oct 31, 2023 | -19.34% |
| Jul 31, 2023 | -22.86% |
| Apr 30, 2023 | -93.92% |
| Jan 31, 2023 | -135.42% |
| Oct 31, 2022 | -87.13% |
| Jul 31, 2022 | -98.00% |
| Apr 30, 2022 | -94.82% |
| Jan 31, 2022 | -108.45% |
| Oct 31, 2021 | -139.02% |
| Jul 31, 2021 | -17.05% |